In terms of the patient outcome, CDK2/CDK4 co-expression influences the survival outcome (overall p = 0.01) (Figure 2F), and this association was maintained in luminal BC (p = 0.033) (Supplementary Figure S3B). The gene discussed is CDK2; the disease is breast cancer.